Literature DB >> 8527072

Comparative assessment of small intestinal and colonic permeability in HIV-infected homosexual men.

F C Obinna1, G Cook, T Beale, S Dave, D Cunningham, S C Fleming, E Claydon, J W Harris, M S Kapembwa.   

Abstract

OBJECTIVES: To investigate both small and large intestinal permeability in HIV-positive subjects, and correlate variation in intestinal mucosal abnormality with immunological and nutritional markers of HIV disease.
METHODS: Small and large intestinal permeability studies were performed in 14 HIV-seropositive patients and eight healthy men. Eight out of the 14 patients had diarrhoea and all subjects were negative for enteropathogens. Small intestinal permeability was determined using the lactulose-mannitol test and large intestinal permeability using the colonic absorption of 51Cr-EDTA. In addition, CD4 cell count, beta 2-microglobulin, C-reactive protein estimation and anthropometry were carried out in all subjects.
RESULTS: HIV-seropositive subjects had higher lactulose-mannitol ratios (LMR; 0.084 +/- 0.007 versus 0.013 +/- 0.0008) and lower 51Cr activity (1.986 +/- 0.066 versus 3.115 +/- 0.560) than controls (P < 0.0004 and P < 0.05, respectively). Colonic uptake of 51Cr-EDTA was no different between subjects with and those without diarrhoea (2.04 +/- 0.124 versus 1.92 +/- 0.143, P > 0.05). A negative correlation was found between LMR and 51Cr-EDTA, but only for patients with diarrhoea (r = -0.81; P = 0.015).
CONCLUSION: Regional variation affecting intestinal absorptive function occurs in patients with HIV-related diarrhoea and is characterized by increased LMR and reduced colonic uptake of 51Cr-EDTA. The pathogenesis and clinical significance of such changes are unknown.

Entities:  

Mesh:

Year:  1995        PMID: 8527072     DOI: 10.1097/00002030-199509000-00005

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  9 in total

Review 1.  Human immunodeficiency virus-associated disruption of mucosal barriers and its role in HIV transmission and pathogenesis of HIV/AIDS disease.

Authors:  Sharof Tugizov
Journal:  Tissue Barriers       Date:  2016-03-03

2.  HIV-associated disruption of mucosal epithelium facilitates paracellular penetration by human papillomavirus.

Authors:  Sharof M Tugizov; Rossana Herrera; Peter Chin-Hong; Piri Veluppillai; Deborah Greenspan; J Michael Berry; Christopher D Pilcher; Caroline H Shiboski; Naomi Jay; Mary Rubin; Aung Chein; Joel M Palefsky
Journal:  Virology       Date:  2013-09-17       Impact factor: 3.616

3.  Gastrointestinal permeability in patients with irritable bowel syndrome assessed using a four probe permeability solution.

Authors:  Arseima Y Del Valle-Pinero; Hendrick E Van Deventer; Nicolaas H Fourie; Angela C Martino; Nayan S Patel; Alan T Remaley; Wendy A Henderson
Journal:  Clin Chim Acta       Date:  2013-01-14       Impact factor: 3.786

4.  Quantitative assessment of altered rectal mucosal permeability due to rectally applied nonoxynol-9, biopsy, and simulated intercourse.

Authors:  Edward J Fuchs; Lisa A Grohskopf; Linda A Lee; Rahul P Bakshi; Craig W Hendrix
Journal:  J Infect Dis       Date:  2013-01-16       Impact factor: 5.226

5.  Enteric ganglionitis in rhesus macaques infected with simian immunodeficiency virus.

Authors:  Marlene S Orandle; Ronald S Veazey; Andrew A Lackner
Journal:  J Virol       Date:  2007-03-28       Impact factor: 5.103

6.  HIV-associated disruption of tight and adherens junctions of oral epithelial cells facilitates HSV-1 infection and spread.

Authors:  Irna Sufiawati; Sharof M Tugizov
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240

7.  Progressive proximal-to-distal reduction in expression of the tight junction complex in colonic epithelium of virally-suppressed HIV+ individuals.

Authors:  Charlotte Y Chung; Stephanie L Alden; Nicholas T Funderburg; Pingfu Fu; Alan D Levine
Journal:  PLoS Pathog       Date:  2014-06-26       Impact factor: 6.823

8.  Rosuvastatin Decreases Intestinal Fatty Acid Binding Protein (I-FABP), but Does Not Alter Zonulin or Lipopolysaccharide Binding Protein (LBP) Levels, in HIV-Infected Subjects on Antiretroviral Therapy.

Authors:  Nicholas T Funderburg; Morgan Boucher; Abdus Sattar; Manjusha Kulkarni; Danielle Labbato; Bruce I Kinley; Grace A McComsey
Journal:  Pathog Immun       Date:  2016

9.  HIV-1 proteins gp120 and tat induce the epithelial-mesenchymal transition in oral and genital mucosal epithelial cells.

Authors:  Kathy Lien; Wasima Mayer; Rossana Herrera; Kristina Rosbe; Sharof M Tugizov
Journal:  PLoS One       Date:  2019-12-23       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.